ArticleFrontiers in cardiovascular medicine2024
Case Report: One-stop procedure for atrial fibrillation patients with dextrocardia.
Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Concomitant Pulsed Field Ablation and Left Atrial Appendage Occlusion for Atrial Fibrillation With Dextrocardia.JACC. Case reports · 2026Article
- Computed tomography-guided left atrial appendage closure in a patient with persistent atrial fibrillation and mirror-image dextrocardia: a case report.Journal of geriatric cardiology : JGC · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of an elderly woman with congenital dextrocardia who experienced severe palpitations. An electrocardiogram revealed paroxysmal atrial fibrillation, and her medical history unveiled cerebral infarction and renal failure. In the treatment of paroxysmal atrial fibrillation, anticoagulation is a key requirement. Although non-vitamin K antagonist oral anticoagulants are recommended by guidelines, their efficacy is compromised in patients undergoing dialysis due to renal metabolism. In addition, warfarin may cause fluctuations in international normalized ratio, which is not conducive to controlling symptoms of cerebral infarction. To improve the patient's quality of life, we focused on addressing the unique challenges posed by dextrocardia in a one-stop procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.